In Minnesota, we’ve lowered prescription drug costs, stabilized insurance costs, and lifted the burden of medical debt.

The claim that Minnesota has lowered prescription drug costs is supported by the state's active pharmaceutical drug price task force and legislative actions aimed at increasing transparency and affordability of medications.ag.state.mn.usag.state.mn.usAdvisory Task Force on Lowering Pharmaceutical Drug Prices These efforts align with broader national trends and policies such as the Inflation Reduction Act that also aim to reduce drug prices.

Regarding insurance costs, while direct evidence from the provided sources is limited, stabilizing insurance costs is a common goal linked to state health policy initiatives and regulatory oversight. The burden of medical debt has been explicitly addressed in Minnesota through the Medical Debt Reset Act announced in early 2025, which aims to relieve residents from undue medical debt.ag.state.mn.usag.state.mn.usAttorney General Ellison, Senator Boldon, and Representative Reyer announce... National data confirm that medical debt remains a significant issue, but Minnesota's targeted legislation represents a concrete step toward alleviating this burden locally.healthsystemtracker.orghealthsystemtracker.orgThe burden of medical debt in the United States - Peterson-KFF Health System...

Overall, while Minnesota's efforts are documented and ongoing, the full extent of cost reductions and stabilization effects may vary among populations and require continued monitoring.